Logo image
Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation
Journal article   Open access   Peer reviewed

Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation

A.M. McDonnell, A.J. Currie, M. Brown, K. Kania, B. Wylie, A. Cleaver, R. Lake and B.W.S. Robinson
OncoImmunology, Vol.1(6), pp.840-846
2012
pdf
antigen_to_the_lymph_node_cross-presentation.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

It is widely accepted that generation of tumor specific CD8+ T-cell responses occur via cross-priming; however the source of tumor antigen for this event is unknown. We examined the source and form of tumor antigen required for cross-presentation in the local lymph node (LN) using a syngeneic mouse tumor model expressing a marker antigen. We found that cross-presentation of this model tumor antigen in the LN is dependent on continuous traffic of antigen from the tumor site, but without any detectable migration of tumor resident dendritic cells (DCs). Instead, small numbers of tumor cells metastasize to local LNs where they are exposed to a localized CTL attack, resulting in delivery of tumor antigen into the cross-presentation pathway.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

240 File views/ downloads
107 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.358 Dendritic Cell Therapy
Web Of Science research areas
Immunology
Oncology
ESI research areas
Biology & Biochemistry
Logo image